Carcinoma, Hepatocellular
Showing NaN - NaN of 27
Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Hepatocellular
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Hefei, Anhui, China
- +22 more
Mar 26, 2014
Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)
Terminated
- Carcinoma, Hepatocellular
- sunitinib malate
- sorafenib
-
Fountain Valley, California
- +170 more
Dec 7, 2012